Cite

HARVARD Citation

    Treue, D. et al. (2019). Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR‐mutated lung cancer. International journal of cancer. 144 (3), pp. 545-557. [Online]. 
  
Back to record